NK
Nkarta, Inc.
NKTX · NASDAQ
$2.95 +1.37% (+$0.04)
1M +11.20%
Market Cap $211.1M
P/E Ratio -
Div. Yield -
ROE 39.64%
Bulios Fair Price
$2.99
1.4% upside
Trenutna cena
$2.95
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price se delnica NKTX trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.85x
P/FCF N/A
P/FFO N/A
Growth
0 /100
Declining Book val. growth 5.68%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROA 34.75%
ROIC 41.15%
Debt
100 /100
Low Current ratio 7.98x
Debt/Equity 0.30x
Net debt/EBITDA N/A
Stability
76 /100
Stable EPS volatility 13.63%
Profitable years 0
Beta 0.98x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NKTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Paul J. Hastings
Employees
106
Headquarters
South San Francisco
Prihajajoči dogodki
10 NOV.
Earnings
Upcoming earnings report